Andere talen Horizon Discovery Group plc

Aandelen

HZD

GB00BK8FL363

Vertraagde tijd London S.E. Andere beurzen			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
- ^GBX	-.--%		-.--%	+23,00%

2022	Medical Device Innovation Consortium (MDIC) werkt samen met Horizon Discovery van PerkinElmer om de nauwkeurigheid van op Next Generation Sequencing gebaseerde kankerdiagnostiek te verbeteren.	CI
2020	Horizon Discovery stijgt met 110% na overname door PerkinElmer in een transactie van $ 366 miljoen	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Medical Device Innovation Consortium Partners with PerkinElmer's Horizon Discovery to Improve Accuracy of Next Generation Sequencing-Based Cancer Diagnostics	19-10-22
Horizon Discovery : Acquisition by PerkinElmer Completes	23-12-20
PerkinElmer (UK) Holdings Ltd. completed the acquisition of Horizon Discovery Group plc from Inclusive Capital Partners, L.P. and others.	23-12-20
Horizon Discovery : Takeover by PerkinElmer Gets Court Approval	22-12-20
GFGW LLC : - Form 8.3 - Horizon Discovery Group Plc	11-12-20
Horizon Discovery : Soars 110% on Acquisition by PerkinElmer in $366 Million Deal	02-11-20
PerkinElmer (UK) Holdings Ltd. agreed to acquire Horizon Discovery Group plc from Inclusive Capital Partners, L.P. and others for approximately £290 million.	02-11-20
Horizon Discovery Group plc Reports Earnings Results for the Half Year Ended June 30, 2020	17-08-20
Horizon Discovery : introduces single cell RNAseq-linked CRISPR screening service	04-08-20
Horizon Discovery Group plc Announces the Addition of Single Cell RNAseq-Linked Pooled CRISPR Screening to Its CRISPR Screening Services Portfolio	04-08-20
Horizon Discovery : Licenses CHOSOURCE Platform to Truebinding for Development and Commercialization of Multiple Biotherapeutics	29-07-20
Horizon Discovery Group plc Licenses Chosource Platform to TrueBinding, Inc for Development and Commercialization of Multiple Biotherapeutics	29-07-20
Horizon Discovery Group plc Provides Group Revenue Guidance for the Six Months Ended June 30, 2020	29-07-20
Horizon Discovery : Introduces Cas9 and dCas9-VPR Stable Cell Lines to Simplify and Accelerate CRISPR Gene Editing Workflows	07-07-20
Horizon Discovery Group plc Introduces Cas9 and dCas9-VPR Stable Cell Lines to Simplify and Accelerate CRISPR Gene Editing Workflows	07-07-20
Horizon Discovery : Rentschler Biopharma Licenses Horizon Discovery’s CHOSOURCE Platform to Complement Cell Line Development Offering for Difficult-To-Express Proteins	19-05-20
Rentschler Biopharma Licenses Horizon Discovery's Chosource Platform to Complement Cell Line Development Offering for Difficult-To-Express Proteins	19-05-20
Horizon Discovery Group plc Announces Board Changes	01-05-20
Horizon Discovery : Full Year Unaudited Results 2019	27-04-20
Horizon Discovery Group plc Unable to Provide Guidance for the Full Year of 2020	27-04-20

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Horizon Discovery Group plc

Aandelen

HZD

GB00BK8FL363

Andere talen

Filters